Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

First Page		Document Content
Date: 2016-01-26 15:03:13 Gilead Sciences Chemistry HIV/AIDS Medicine Organofluorides Specialty drugs Prodrugs Prevention of HIV/AIDS AIDS Healthcare Foundation Tenofovir alafenamide Tenofovir disoproxil Fixed-dose combination		Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No Add to Reading List Source URL: www.aidshealth.org Download Document from Source Website File Size: 985,53 KB Share Document on Facebook

	Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No DocID: 1rqYi - View Document
	UNITED STATES of AMERICA EXPERT HIV HEALTHCARE AHF’s path to becoming the largest provider of HIV/AIDS care in the U.S. began with a small group of dedicated activists in Los Angeles in the 1980s who had a simple DocID: 1rhxq - View Document
	aids healthcare foundation 2005 Annual Report an independent voice California DocID: 1rdHV - View Document
	KEEPING THE PROMISE AIDS HEALTHCARE FOUNDATION >> Progress Report OUR MISSION Cutting-edge medicine and DocID: 1q0Ej - View Document
	LATIN AMERICA LATIN AMERICA QUALITY HIV CARE & NEW FRONTIERS AIDS Healthcare Foundation (AHF), DocID: 1pLwC - View Document